Exploring Paxlovid as a Treatment Option for COVID-19

Exploring Paxlovid as a Treatment Option for COVID-19

John Whyte, MD

Disclosures

May 12, 2022

14

Exploring Paxlovid as a Treatment Option for COVID-19
Exploring Paxlovid as a Treatment Option for COVID-19
00:00
00:0002:24GO LIVE

Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.

JOHN WHYTE: Hello. I'm Dr. John Whyte. I'm the chief medical officer at WebMD.

You test positive for COVID, and you're not feeling well. What do you do? Specifically, what's the role of antivirals?

You might have heard about a drug called Paxlovid. Well, Paxlovid is a pill that you take by mouth, as opposed to some other therapies that are injections or infusions. It's indicated if you're 12 years of age or older, you weigh at least 88 pounds, and you test positive for coronavirus, and you're at high risk for hospitalization.

What does that mean? That means you either have certain underlying conditions, such as cancer, diabetes, rheumatoid arthritis, or obesity, or you're an older adult. Again, it's an oral pill. You take three pills a day, twice a day for 5 days, a total of 30 pills.

It's actually two separate medications, Ritonavir and Nirmatrelvir. They're designed to stop the virus from replicating. That's why it's called an antiviral. The data showed that participants in a trial who were given Paxlovid were 89% less likely to develop severe illness and death, compared to trial participants who received a placebo.

Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....